The Combined Metabolic Action of Tirzepatide via GLP-1 & GIP
GIP and GLP-1 receptor activation provides complementary metabolic actions that improve overall glucose and energy homeostasis. Together, they enhance glucose-dependent insulin secretion, improve insulin sensitivity, and promote appropriate glucagon regulation, resulting in improved glycemic control. Their coordinated effects on the brain, gastrointestinal tract, adipose tissue, liver, and skeletal muscle contribute to reduced appetite and energy intake, improved glucose and lipid metabolism, and enhanced metabolic flexibility.
Collectively, these actions support sustained glycemic control, reduced body weight, and broader cardiometabolic health.
Twincretin Effect: GLP-1 + GIP Synergy
Integrated Effects on Key Systems
Tirvox operates concurrently across central and peripheral anatomical sites to reverse the underlying pathophysiology of type 2 diabetes and chronic weight management.
Brain / Central Nervous System
GIP Effect
- GIP increases satiety signaling in the brain.
- GIP supports appetite regulation through central nervous system pathways.
GLP-1 Effect
- GLP-1 increases satiety.
- GLP-1 decreases appetite and food intake.
Overall Effect
- Enhanced appetite control leads to reduced energy intake, which in turn supports weight loss.
Ready to Explore Proven Efficacy?
See how the dual incretin mechanism translates into real-world weight loss, glycemic control, and cardiometabolic improvements across landmark clinical trial programs.